• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Relationships between physicians and Pharma: Why physicians should not accept money from the pharmaceutical industry.

作者信息

Elliott Carl

机构信息

Center for Bioethics, University of Minnesota, Minneapolis.

出版信息

Neurol Clin Pract. 2014 Apr;4(2):164-167. doi: 10.1212/CPJ.0000000000000012.

DOI:10.1212/CPJ.0000000000000012
PMID:29443239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5765617/
Abstract
摘要

相似文献

1
Relationships between physicians and Pharma: Why physicians should not accept money from the pharmaceutical industry.医生与制药行业的关系：为何医生不应接受制药行业的资金。
Neurol Clin Pract. 2014 Apr;4(2):164-167. doi: 10.1212/CPJ.0000000000000012.
2
Physicians in the pharmaceutical industry: their roles, motivations, and perspectives.制药行业的医师：他们的角色、动机和观点。
Drug Discov Today. 2019 Sep;24(9):1865-1870. doi: 10.1016/j.drudis.2019.05.021. Epub 2019 May 31.
3
[THE INFLUENCE OF THE ISRAELI LEGISLATION ON THE RELATIONSHIP BETWEEN PHYSICIANS AND PHARMACEUTICAL COMPANIES].
Harefuah. 2016 Jul;155(7):426-430.
4
[The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].[医生对制药行业推广策略的态度]
Medicina (B Aires). 2005;65(3):247-51.
5
Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.医生与药品销售代表及制药公司的关系：一项探索性研究。
Health Mark Q. 1996;13(4):79-89. doi: 10.1300/J026v13n04_07.
6
Breaking up is hard to do: lessons learned from a pharma-free practice transformation.打破常规并不容易：从无制药业务的实践转型中吸取的经验教训。
J Am Board Fam Med. 2013 May-Jun;26(3):332-8. doi: 10.3122/jabfm.2013.03.120268.
7
Interaction between physicians and pharmaceutical representatives, an insight from Thailand.
J Med Assoc Thai. 2014 Mar;97 Suppl 3:S223-31.
8
Do ethical Guidelines make a difference to decision-making?伦理准则对决策有影响吗？
Intern Med J. 2009 Dec;39(12):800-5. doi: 10.1111/j.1445-5994.2009.01954.x. Epub 2009 Mar 23.
9
How should we support pharmaceutical innovation?我们应该如何支持药物创新？
Expert Rev Pharmacoecon Outcomes Res. 2009 Aug;9(4):313-20. doi: 10.1586/erp.09.34.
10
Doctors and pharmaceutical industry.
Med Law. 2009 Sep;28(3):541-55.

引用本文的文献

1
Current controversies: Physicians vs Pharma.当前的争议：医生与制药公司的矛盾
Neurol Clin Pract. 2014 Aug;4(4):273-276. doi: 10.1212/01.CPJ.0000453548.28686.47.
2
Current controversies: Physicians vs Pharma.当前的争议：医生与制药公司
Neurol Clin Pract. 2014 Oct;4(5):374-375. doi: 10.1212/01.CPJ.0000455830.98060.e5.
3
Steps to strengthen ethics in organizations: research findings, ethics placebos, and what works.加强组织道德规范的步骤：研究结果、道德安慰剂及有效方法。
J Trauma Dissociation. 2015;16(2):139-52. doi: 10.1080/15299732.2015.995021. Epub 2015 Jan 20.

本文引用的文献

1
Introduction: Institutional corruption and the pharmaceutical policy.引言：制度腐败与药品政策。
J Law Med Ethics. 2013 Fall;41(3):544-52. doi: 10.1111/jlme.12062.
2
Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial.加巴喷丁疗效滴定与安全性研究（STEPS）试验：加巴喷丁导入试验的叙述性报告
Arch Intern Med. 2011 Jun 27;171(12):1100-7. doi: 10.1001/archinternmed.2011.241.
3
The Neurontin legacy--marketing through misinformation and manipulation.加巴喷丁的遗留问题——通过错误信息和操纵手段进行营销。
N Engl J Med. 2009 Jan 8;360(2):103-6. doi: 10.1056/NEJMp0808659.
4
Evidence in Vioxx suits shows intervention by Merck officials.万络诉讼案中的证据显示了默克公司官员的干预行为。
N Y Times Web. 2005 Apr 24:A1, A32.